IL23A and systemic sclerosis: Recently, a strong correlation between the onset of the disease, the initiation of pulmonary fibrosis, and the increase of IL-23 expression has been demonstrated, suggesting that Th17, stimulated by IL-23, is involved in the onset of SSc, but not in disease progression [78].